Early response to OAB treatment predicts long-term therapeutic success

Athens, Greece?Early response to treatment with an investigational anticholinergic agent for overactive bladder appears to be an accurate predictor of long-term therapeutic success, according to data recently presented at the AUA New York Section meeting.

Related Content:

Drug Therapy

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria

FDA approves androgen inhibitor for metastatic PCa